ReviewClinical pharmacokinetics2017
Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax.
Madeline Waldron et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it